This article is going to make everyone a little uncomfortable, because it refuses to pick a side. Finasteride skeptics won't like that we present the clinical trial data showing low incidence rates. Finasteride advocates won't like that we take the neurosteroid mechanism seriously. That discomfort is the point — the truth sits in the middle, and understanding it requires holding two things at once.
The Clinical Trial Numbers
Let's start with the hardest data available: the Merck Phase III clinical trials that got finasteride approved. 1,879 men. Randomized. Placebo-controlled. Double-blinded. This is the gold standard.
| Side Effect | Finasteride 1mg | Placebo | Absolute Difference |
|---|---|---|---|
| Decreased libido | 1.8% | 1.3% | 0.5% |
| Erectile dysfunction | 1.3% | 0.7% | 0.6% |
| Ejaculation disorders | 1.2% | 0.7% | 0.5% |
| Overall sexual AE | 3.8% | 2.1% | 1.7% (p=0.04) |
The overall sexual adverse event rate was 3.8% on finasteride vs 2.1% on placebo. That's statistically significant (p=0.04), meaning finasteride genuinely does cause sexual side effects in some men above and beyond what placebo produces. But the absolute numbers are small — for each individual side effect, the difference attributable to the drug is well under 1%.
Two critical details that change the picture further:
Side effect incidence decreased to ≤0.3% by year five. The side effects that do occur tend to emerge in the first year and then diminish — not accumulate — over time. The 5-year PLESS trial showed no significant difference between finasteride and placebo in sexual AEs during years 2–4.
Most side effects resolved in men who continued therapy. This is an underappreciated finding. Many men who experienced early sexual side effects saw them resolve even while staying on finasteride — suggesting adaptation or tolerance development.
The Nocebo Factor
The Mondaini study (Journal of Sexual Medicine, 2007) divided men starting finasteride into two groups: those informed about potential sexual side effects, and those not informed. The results are striking.
When Informed
When Not Informed
Stopping (Informed)
With Awareness
Men who were told about possible sexual side effects reported them at nearly three times the rate of men who weren't told. And in the informed group, the effects resolved completely within 5 days of discontinuation — suggesting psychological rather than pharmacological causation.
This does not mean finasteride side effects are imaginary. What it means is that expectation and anxiety significantly amplify self-reported sexual symptoms. If you've spent hours reading horror stories on Reddit before starting finasteride, you are statistically more likely to attribute normal fluctuations in libido or erectile function to the drug.
The Neurosteroid Mechanism (Why It's Not Just Nocebo)
Here's where we part company with the pure reassurance crowd. Finasteride doesn't just block DHT production. It also inhibits neurosteroidogenesis — the production of neurosteroids in the brain and nervous system.
5-alpha reductase is involved in producing several neurosteroids: allopregnanolone, 3α-androstanediol, and THDOC. These are GABAA receptor modulators with antidepressant, anxiolytic (anti-anxiety), and prosexual effects.
Finasteride reduces their levels. This provides a plausible biological mechanism for mood changes, anxiety, and sexual side effects that goes beyond simple DHT reduction — and it explains why a small subset of men may be more susceptible based on their individual neurosteroid metabolism.
The 2025 FAERS (FDA Adverse Event Reporting System) analysis added another layer: adverse event reporting for finasteride increased significantly after 2012, when the PFS Foundation launched public awareness campaigns. This suggests reporting bias (more awareness → more reports) but does not prove that earlier, lower reporting rates reflected the true incidence. Both interpretations have validity.
What to Do If You Experience Side Effects
If you notice changes in libido, erectile function, or ejaculation after starting finasteride, you have several evidence-based options before discontinuing entirely:
1. Wait and monitor (2–4 weeks)
Many early-onset side effects resolve spontaneously within weeks, even with continued use. The clinical trial data supports this — side effect rates decreased over time in men who continued therapy.
2. Reduce the dose
Drop from 1 mg daily to 0.5 mg daily or 1 mg every other day. You'll still achieve meaningful DHT suppression with lower systemic drug exposure. The dose-response curve is very flat above 0.5 mg.
3. Switch to topical finasteride
Topical application achieves meaningful scalp DHT reduction with plasma finasteride levels over 100-fold lower than oral. The 2026 Gupta pharmacovigilance study found oral finasteride generated significantly more adverse event reports than topical across all categories.
4. Add ED treatment if needed
If the primary issue is erectile function, PDE5 inhibitors (sildenafil, tadalafil) work through a completely separate mechanism and have no interaction with finasteride. Daily low-dose tadalafil is the most convenient option.
5. Discontinue
If side effects are persistent and impacting your quality of life, stopping is a legitimate choice. Effects of oral finasteride are fully reversible — DHT normalizes within 14 days, and any drug-related sexual side effects should resolve. If they don't resolve within a few months, talk to your provider.
6. Talk to someone
Anxiety about side effects can create and amplify symptoms through the nocebo effect. If you're experiencing significant worry about finasteride's impact on your sexual health, talking to a mental health professional can help you separate drug effects from anxiety effects.
Discuss Your Concerns With a Provider
A licensed provider can help you assess whether your symptoms are drug-related and find the right approach for your situation.
Find a ProviderAffiliate link · Sesame Care · Consultations from $44
Finasteride causes sexual side effects in a small minority of users: 3.8% overall vs 2.1% on placebo, with individual symptoms (ED, libido, ejaculation) each affecting under 2%. The nocebo effect is powerful — men informed about side effects report them at 3× the rate of uninformed men. But the neurosteroid mechanism provides genuine biological plausibility for mood and sexual changes in susceptible individuals. Side effects typically emerge early and decrease over time (≤0.3% by year 5). Options include dose reduction, topical switch, concurrent ED treatment, or discontinuation. None of this is dismissal; none of it is fear-mongering. It's the data.